Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban reveals an industry where fraud is rampant, companies routinely falsify data and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Eban is a Fortune magazine contributor and Andrew Carnegie Fellow, and her work has been featured in Vanity Fair, NY Times, Self, The Nation, the New York Observer, 60 Minutes, Nightline, NPR, and more.
Katherine Eban has also been featured in:
Bottle of Lies: The Inside Story of the Generic Drug BoomBuy
- Related Episodes